Statistics for Kuros Biosciences AG (id:13176 KURN)

Valuation metrics

Market cap

934.54M

Enterprise value

514.13M

Trailing P/E (ttm)

-58.95

Forward P/E

PEG ratio

5.07

Price/Sales (ttm)

17.79

Price/Book (mrq)

8.75

Enterprise Value/Revenue

9.78

Enterprise Value/EBITDA

-168.57

Overview

Shares outstanding

37.46M

Float

14.15M

Shares short

% Held by insiders

0.32%

% Held by institutions

0.13%

Average volume (10 days)

346.07K

Average volume (90 days)

Price summary

52-Week low

3.06

52-Week high

32.00

52-Week change

83.17%

Beta

0.76

50-Day moving average

22.44

200-Day moving average

12.64

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

October 08th, 2020

Ex-dividend date

Last split factor

2:1

Last split date

June 23th, 2016

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-16.91%

Operating margin

-1.75%

Operational effectiveness

Return on assets

-3.77%

Return on equity

-14.32%

Income statement

Revenue (ttm)

1.81

Revenue per share (ttm)

1.81

Quarterly revenue growth (yoy)

Gross profit (ttm)

23.94M

EBITDA

-3,050,000.00

Net income to common (ttm)

-8,886,000.00

Diluted EPS (ttm)

-0.25

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

14.28M

Total cash per share (mrq)

0.68

Total debt (mrq)

1.96M

Total Debt/Equity (mrq)

3.26

Current ratio (mrq)

273.30%

Book value per share (mrq)

2.85

Cash flow

Cash flow statement

-2,415,000.00

Levered free cash flow (LFCF)

-6,043,375.00